You just read:

Novartis Presents New Real World Evidence Data at ASH from the TARGET UK CML Study Comparing Current UK Clinical Practice with Existing European LeukemiaNet (ELN) 2013 Guidelines

News provided by

Novartis UK

11 Dec, 2017, 07:00 GMT